Skip to the page

Data / Form D filings / Aurita Corp

Aurita Corp: Form D filings

Aurita Corp, a biotechnology company in Gainesville, FL, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on May 24, 2024, reports $180,491 sold of a $400,000 offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
107 SW 7TH STREET, Gainesville, FL, 32601
Phone
(435) 300-0470
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1937883

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 24, 2024New notice$400,000$180,491$219,5093May 10, 2024sec.gov
Jul 13, 2022New notice$1,111,111$1,000,000$111,1111Jul 5, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Richard BlaserDirector
Wallace Gregory SawyerExecutive Officer, Director
Joe MiletichExecutive Officer, Director, Promoter
Stephanie WarringtonDirector
Gregory KisDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of May 20, 2024 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Aurita Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.